Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2023-09-15 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULES 5.05(1), 5.06, 5.28, 5.33 AND 5.36A OF THE GEM LISTING RULES
Board/Management Information Classification · 100% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the appointment of an independent non-executive director and compliance with specific GEM Listing Rules. It details the new director's background, terms, and compliance with listing rules. There are no financial statements, earnings data, or report attachments. The content focuses on board/management changes and regulatory compliance announcements related to governance. This fits the category of Board/Management Information (MANG). The document length (5534 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2023-09-15 English
COMPANY INFORMATION SHEET
Regulatory Filings Classification · 95% confidence The document is titled 'Company Information Sheet' and is a form (Form F) related to listing on the GEM of The Stock Exchange of Hong Kong Limited. It contains detailed company information such as directors, shareholders, share options, business activities, and compliance statements. It is not a financial report, earnings release, or management discussion. It is a regulatory filing required by the exchange to provide updated company particulars. The document length is 8227 characters, which is substantial but the content is informational and compliance-related rather than financial reporting. There is no indication that this is an announcement of a report or a certification letter. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-09-12 English
(REVISED) MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return regarding movements in securities for Sinopharm Tech Holdings Limited, including changes in authorized and issued share capital, share options, and share consolidations. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content focuses on share capital changes, share consolidations, and confirmations related to securities issuance. There are no financial statements, earnings data, or management discussion of financial results. The document is regulatory in nature, reporting share capital movements and confirmations to the stock exchange, which fits the category of Share Issue/Capital Change announcements rather than a full financial report or other categories. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a substantive regulatory filing on capital changes.
2023-09-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on share capital changes, issued shares, share options, and confirmations related to securities issued by Sinopharm Tech Holdings Limited. It includes data on share consolidation, share options adjustments, and confirmations by the company secretary. The document is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. It is not a financial report like an annual or interim report, nor is it an earnings release or a management discussion. It is a regulatory filing that reports on share capital movements and related confirmations, which fits the category of Regulatory Filings (RNS) as it does not fall into more specific categories like Share Issue/Capital Change (SHA) because it is a monthly return form (FF301) submitted to the exchange, a standard regulatory compliance document. The document length and content confirm it is a substantive regulatory filing rather than a brief announcement or a report publication notice.
2023-09-06 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Sinopharm Tech Holdings Limited. It references compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. The content details a capital reorganization (share consolidation) and confirms authorization by the board of directors. The document is a regulatory disclosure about share capital changes rather than a full financial report or earnings release. It is not a report itself but a regulatory filing disclosing capital changes and compliance confirmations. Therefore, it fits best under 'Regulatory Filings' (RNS). The document length (7448 characters) and detailed content support this classification with high confidence.
2023-08-29 English
COMPANY INFORMATION SHEET
Regulatory Filings Classification · 95% confidence The document is titled 'Company Information Sheet' and is a form (Form F) related to listing on the GEM of The Stock Exchange of Hong Kong Limited. It contains detailed company information such as directors, shareholders, share options, business activities, and compliance statements. It is not a financial report, earnings release, or management discussion. It is a regulatory filing providing updated company particulars as required by listing rules. The document length is 8335 characters, which is substantial but the content is informational rather than financial reporting. There is no indication that this is an announcement of a report publication or a certification letter. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-08-28 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.